Table 1.

St-PGA-CL-BDMC characterization including drug loading, size and zeta potential.

Compound	wt% BDMCa	Size (Rh, nm)b	Z-pot (mV)c
St-PGA-CL-BDMC	14.9%	40.2 ± 2.4	−38.6 ± 2.2

^aDetermined by UV-VIS at 405 nm.

^bDetermined by dynamic light scattering techniques using a conjugate solution of 1 mg/mL in ddH₂O. Size expressed in number mean.

^cDetermined using Zetasizer using a conjugate solution of 1 mg/mL in 1 mM solution of KCl.